Jiangxi Bilin Industrial Co., Ltd. announced that it would receive CNY 20,000,000 in an equity round of funding from new investor Zhejiang Hisoar Pharmaceutical Co., Ltd. on January 28, 2022. After completion of the transaction, the investor will hold 34% stake in the company. The transaction has been reviewed and approved at the 18th meeting of the 6th board of directors of the investor, and does not need to be submitted to the general meeting of its shareholders for consideration.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.36 CNY | +0.79% | -3.05% | -11.54% |
28/04 | Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
18/04 | Hisoar Pharma's Unit Passes German Health Regulator's Inspection | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.54% | 1.39B | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- 002099 Stock
- News Zhejiang Hisoar Pharmaceutical Co., Ltd.
- Jiangxi Bilin Industrial Co., Ltd. announced that it expects to receive CNY 20 million in funding from Zhejiang Hisoar Pharmaceutical Co., Ltd.